Literature DB >> 17459922

Atypical bZIP domain of viral transcription factor contributes to stability of dimer formation and transcriptional function.

Celine Schelcher1, Salama Al Mehairi, Elizabeth Verrall, Questa Hope, Kirsty Flower, Beth Bromley, Derek N Woolfson, Michelle J West, Alison J Sinclair.   

Abstract

The Epstein-Barr virus transcription factor Zta (encoded by BZLF1) is a bZIP protein containing an alpha-helical coiled-coil homodimerization motif (zipper). The Zta zipper forms less-stable dimers than other bZIP proteins, and an adjacent region (CT) interacts with the zipper to form a novel structure that is proposed to strengthen the dimer. Here we question the role of the CT region for Zta function. Cross-linking experiments demonstrate that the entire CT region lies adjacent to the zipper. Detailed analyses of Zta truncation mutations identify an involvement of the proximal CT region (221 to 230) in dimer formation with a further contribution from the distal region (236 to 243). Biophysical analyses reveal that residues 221 to 230 enhance the stability of the coiled coil. The ability of the Zta truncation mutants to interact with three Zta-binding sites also requires the proximal CT region. Fine mapping of DNA-binding requirements highlighted the contribution of these amino acids for Zta function. Thus, the proximal part of the CT region is required to aid the dimerization of Zta and thereby its DNA-binding ability. In contrast, although the distal part of the CT region aids dimerization, it promotes only a modest increase in DNA binding. To probe this further, we defined the contribution from the CT region for Zta to transactivate a promoter embedded within the viral genome. From this we conclude that the proximal part of the CT region is absolutely required, whereas the distal part is dispensable.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459922      PMCID: PMC1933325          DOI: 10.1128/JVI.00215-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.

Authors:  R Feederle; M Kost; M Baumann; A Janz; E Drouet; W Hammerschmidt; H J Delecluse
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

Review 2.  Epstein-Barr virus-recent advances.

Authors:  Karen F Macsween; Dorothy H Crawford
Journal:  Lancet Infect Dis       Date:  2003-03       Impact factor: 25.071

3.  Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C.

Authors:  Michelle J West; Helen M Webb; Alison J Sinclair; Derek N Woolfson
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

4.  The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome.

Authors:  Prasanna M Bhende; William T Seaman; Henri-Jacques Delecluse; Shannon C Kenney
Journal:  Nat Genet       Date:  2004-09-12       Impact factor: 38.330

5.  trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment.

Authors:  K Takada; N Shimizu; S Sakuma; Y Ono
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

6.  Biophysical analysis of natural variants of the multimerization region of Epstein-Barr virus lytic-switch protein BZLF1.

Authors:  M R Hicks; S Balesaria; C Medina-Palazon; M J Pandya; D N Woolfson; A J Sinclair
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

Review 7.  bZIP proteins of human gammaherpesviruses.

Authors:  Alison J Sinclair
Journal:  J Gen Virol       Date:  2003-08       Impact factor: 3.891

8.  The zipper region of Epstein-Barr virus bZIP transcription factor Zta is necessary but not sufficient to direct DNA binding.

Authors:  Matthew R Hicks; Salama S Al-Mehairi; Alison J Sinclair
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

9.  Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.

Authors:  A Chevallier-Greco; E Manet; P Chavrier; C Mosnier; J Daillie; A Sergeant
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598

10.  Unexpected structure of Epstein-Barr virus lytic cycle activator Zta.

Authors:  Alison J Sinclair
Journal:  Trends Microbiol       Date:  2006-05-26       Impact factor: 17.079

View more
  11 in total

1.  Design of peptide inhibitors that bind the bZIP domain of Epstein-Barr virus protein BZLF1.

Authors:  T Scott Chen; Aaron W Reinke; Amy E Keating
Journal:  J Mol Biol       Date:  2011-02-25       Impact factor: 5.469

2.  Efficient induction of nuclear aggresomes by specific single missense mutations in the DNA-binding domain of a viral AP-1 homolog.

Authors:  Richard Park; Ruth Wang'ondu; Lee Heston; Duane Shedd; George Miller
Journal:  J Biol Chem       Date:  2011-01-13       Impact factor: 5.157

3.  The integrity of the periplasmic domain of the VirA sensor kinase is critical for optimal coordination of the virulence signal response in Agrobacterium tumefaciens.

Authors:  Gauri R Nair; Xiaoqin Lai; Arlene A Wise; Benjamin Wonjae Rhee; Mark Jacobs; Andrew N Binns
Journal:  J Bacteriol       Date:  2011-01-07       Impact factor: 3.490

4.  Interaction of Epstein-Barr virus BZLF1 C-terminal tail structure and core zipper is required for DNA replication but not for promoter transactivation.

Authors:  Carol M McDonald; Carlo Petosa; Paul J Farrell
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

5.  Functional interaction between Epstein-Barr virus replication protein Zta and host DNA damage response protein 53BP1.

Authors:  Sarah G Bailey; Elizabeth Verrall; Celine Schelcher; Alex Rhie; Aidan J Doherty; Alison J Sinclair
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

6.  Human T-cell leukemia virus type 3 (HTLV-3) and HTLV-4 antisense-transcript-encoded proteins interact and transactivate Jun family-dependent transcription via their atypical bZIP motif.

Authors:  Émilie Larocque; Charlotte André-Arpin; Malgorzata Borowiak; Guy Lemay; William M Switzer; Madeleine Duc Dodon; Jean-Michel Mesnard; Benoit Barbeau
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

7.  Ubiquitin Modification of the Epstein-Barr Virus Immediate Early Transactivator Zta.

Authors:  Mengmeng Zhao; Asuka Nanbo; David Becnel; Zhiqiang Qin; Gilbert F Morris; Li Li; Zhen Lin
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

8.  Analysis of an ankyrin-like region in Epstein Barr Virus encoded (EBV) BZLF-1 (ZEBRA) protein: implications for interactions with NF-κB and p53.

Authors:  David H Dreyfus; Yang Liu; Lucy Y Ghoda; Joseph T Chang
Journal:  Virol J       Date:  2011-09-05       Impact factor: 4.099

9.  The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1.

Authors:  James Heather; Kirsty Flower; Samine Isaac; Alison J Sinclair
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

10.  BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.

Authors:  Anne Woellmer; Jose M Arteaga-Salas; Wolfgang Hammerschmidt
Journal:  PLoS Pathog       Date:  2012-09-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.